Peer-reviewed article
Predicting the Risk of Proteinuria Based on Blood Plasma Fourier-Transform Infrared Spectroscopy and Machine Learning Algorithms From Pregnant Women and Newborns.
Camila Lopes Ferreira, Sara Maria Santos Dias da Silva, Luma Martins Aleixo de Oliveira, Vitórya Carvalho Pádua de Magalhães, Simone Lima Silva et al. ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This is a technical study on using infrared spectroscopy and machine learning to detect proteinuria (excess protein in urine) in blood samples from pregnant women and newborns. The research tested diagnostic accuracy of the method across four groups and reported high sensitivity and specificity for newborns. While proteinuria can indicate preeclampsia which affects maternal and fetal health, the study is focused on developing a diagnostic tool rather than evaluating interventions for child well-being.
Key points
- The study achieved 76.1% accuracy for detecting proteinuria in pregnant women and 90.6% accuracy in newborns using spectroscopy and machine learning
- Proteinuria is associated with increased risk of preterm birth and low birth weight
- Fourier-transform infrared spectroscopy was used to analyze blood plasma samples from 51 total participants
- Results suggest the diagnostic method could be useful for early detection and monitoring of proteinuria
- Authors note that larger, more diverse populations are needed to validate the methodology
Limitations
This is a methodological study developing a diagnostic tool rather than evaluating an intervention with child health outcomes. The small sample sizes (12-14 per group) and lack of reported long-term follow-up data on actual child health impacts limit what can be concluded about benefit to children.
Abstract
Proteinuria, defined by an abnormally elevated concentration of proteins in the urine, serves as a critical biomarker for the early detection and diagnosis of preeclampsia. Elevated proteinuria levels adversely affect both maternal and foetal health, increasing the risk of preterm birth and low birth weight. This study focused on the identification of proteinuria in blood samples through Fourier-transform infrared (FTIR) spectroscopy as a diagnostic tool for real-time diagnosis. Blood plasma collected during birth was evaluated in four study groups: pregnant controls (n = 12), pregnant women with proteinuria (n = 13), newborn controls (n = 12), newborns with proteinuria (n = 14). First, attenuated total reflectance-FTIR spectra of plasma samples were collected for subsequent spectral smoothing, vector normalisation and machine-learning classification with various supervised machine learning algorithms, including several types of Support Vector Machine, K-Nearest Neighbours and decision trees. We obtained (76.1 ± 3.1)% accuracy, (72.1 ± 4.8)% sensitivity and (80.4 ± 3.8)% specificity for pregnant classification, and (90.6 ± 1.5)% accuracy, (83.3 ± 2.4)% sensitivity and (98.9 ± 1.6)% specificity for newborn classification. The vibrational modes corresponding to the predominant biochemical components in blood plasma of pregnant women and newborns were listed. Sensitivity and specificity results demonstrated that FTIR can be a promising tool for early diagnosis and monitoring of individual proteinuria. Although the proposed spectroscopic approach demonstrated promising diagnostic performance, the findings should be interpreted in light of clinical conditions that could affect the biochemical profile. Further studies involving larger and more heterogeneous populations are required to validate the proposed methodology.